179 related articles for article (PubMed ID: 17117100)
1. Efficacy of botulinum toxin type a after topical anesthesia.
Sami MS; Soparkar CN; Patrinely JR; Hollier LM; Hollier LH
Ophthalmic Plast Reconstr Surg; 2006; 22(6):448-52. PubMed ID: 17117100
[TBL] [Abstract][Full Text] [Related]
2. Investigating the efficacy of vibration anesthesia to reduce pain from cosmetic botulinum toxin injections.
Sharma P; Czyz CN; Wulc AE
Aesthet Surg J; 2011 Nov; 31(8):966-71. PubMed ID: 22001341
[TBL] [Abstract][Full Text] [Related]
3. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
Ababneh OH; Cetinkaya A; Kulwin DR
Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
[TBL] [Abstract][Full Text] [Related]
4. Results of botulinum toxin: an application to blepharospasm Schwartz-Jampel syndrome.
Vargel I; Canter HI; Topaloglu H; Erk Y
J Craniofac Surg; 2006 Jul; 17(4):656-60. PubMed ID: 16877909
[TBL] [Abstract][Full Text] [Related]
5. Difference in response to botulinum toxin type A treatment between patients with benign essential blepharospasm and hemifacial spasm.
Cannon PS; MacKenzie KR; Cook AE; Leatherbarrow B
Clin Exp Ophthalmol; 2010 Oct; 38(7):688-91. PubMed ID: 20456439
[TBL] [Abstract][Full Text] [Related]
6. Skin cooling before periocular botulinum toxin A injection.
Linder JS; Edmonson BC; Laquis SJ; Drewry RD; Fleming JC
Ophthalmic Plast Reconstr Surg; 2002 Nov; 18(6):441-2. PubMed ID: 12439058
[TBL] [Abstract][Full Text] [Related]
7. Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia.
Xiao L; Mackey S; Hui H; Xong D; Zhang Q; Zhang D
Pain Med; 2010 Dec; 11(12):1827-33. PubMed ID: 21134121
[TBL] [Abstract][Full Text] [Related]
8. Reduction of pain and anxiety prior to botulinum toxin injections with a new topical anesthetic method.
Weiss RA; Lavin PT
Ophthalmic Plast Reconstr Surg; 2009; 25(3):173-7. PubMed ID: 19454924
[TBL] [Abstract][Full Text] [Related]
9. Corneal and Tear Film Changes After Botulinum Toxin-A in Blepharospasm or Hemifacial Spasm.
Gunes A; Demirci S; Koyuncuoglu HR; Tok L; Tok O
Cornea; 2015 Aug; 34(8):906-10. PubMed ID: 26075455
[TBL] [Abstract][Full Text] [Related]
10. Treatment of blepharospasm with botulinum neurotoxin type A: long-term results.
Calace P; Cortese G; Piscopo R; Della Volpe G; Gagliardi V; Magli A; De Berardinis T
Eur J Ophthalmol; 2003 May; 13(4):331-6. PubMed ID: 12872788
[TBL] [Abstract][Full Text] [Related]
11. Effect of dietary zinc and phytase supplementation on botulinum toxin treatments.
Koshy JC; Sharabi SE; Feldman EM; Hollier LH; Patrinely JR; Soparkar CN
J Drugs Dermatol; 2012 Apr; 11(4):507-12. PubMed ID: 22453589
[TBL] [Abstract][Full Text] [Related]
12. A randomized, placebo-controlled, crossover clinical trial of super blue-green algae in patients with essential blepharospasm or Meige syndrome.
Vitale S; Miller NR; Mejico LJ; Perry JD; Medura M; Freitag SK; Girkin C
Am J Ophthalmol; 2004 Jul; 138(1):18-32. PubMed ID: 15234278
[TBL] [Abstract][Full Text] [Related]
13. Long-term treatment of blepharospasm with botulinum toxin A: a service-based study over a 16-year follow-up in southern China.
Fang XB; Xie MS; Song ZB; Zhong ZG; Wang Y; Ou ZL; Dang C; Li L; Zhang WX
Neurol Sci; 2020 Mar; 41(3):645-652. PubMed ID: 31745757
[TBL] [Abstract][Full Text] [Related]
14. Dilution of botulinum toxin A in lidocaine vs. in normal saline for the treatment of primary axillary hyperhidrosis: a double-blind, randomized, comparative preliminary study.
Güleç AT
J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):314-8. PubMed ID: 21492253
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin in facial rejuvenation: an update.
Carruthers J; Carruthers A
Dermatol Clin; 2009 Oct; 27(4):417-25, v. PubMed ID: 19850191
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin injection and tear production.
Alsuhaibani AH; Eid SA
Curr Opin Ophthalmol; 2018 Sep; 29(5):428-433. PubMed ID: 29994851
[TBL] [Abstract][Full Text] [Related]
17. Anesthesia with EMLA cream for botulinum A toxin injection into eyelids.
Söylev MF; Koçak N; Kuvaki B; Ozkan SB; Kir E
Ophthalmologica; 2002; 216(5):355-8. PubMed ID: 12424403
[TBL] [Abstract][Full Text] [Related]
18. High versus low concentration botulinum toxin A for benign essential blepharospasm: does dilution make a difference?
Boyle MH; McGwin G; Flanagan CE; Vicinanzo MG; Long JA
Ophthalmic Plast Reconstr Surg; 2009; 25(2):81-4. PubMed ID: 19300145
[TBL] [Abstract][Full Text] [Related]
19. Botulinum A toxin treatment for blepharospasm and Meige syndrome: report of 100 patients.
Poungvarin N; Devahastin V; Chaisevikul R; Prayoonwiwat N; Viriyavejakul A
J Med Assoc Thai; 1997 Jan; 80(1):1-8. PubMed ID: 9078810
[TBL] [Abstract][Full Text] [Related]
20. Long-term Efficacy of Botulinum Neurotoxin-A Treatment for Essential Blepharospasm.
Lee S; Park S; Lew H
Korean J Ophthalmol; 2018 Feb; 32(1):1-7. PubMed ID: 29376224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
